News Conference News ESOC 2025 Less Intense Checks May Be OK After IV Thrombolysis for Stroke: OPTIMISTmain Todd Neale May 28, 2025
News Conference News ESOC 2025 ASSET-IT: Tirofiban Boosts Outcomes After IV Thrombolysis for Acute Stroke Todd Neale May 27, 2025
News Conference News ESOC 2025 IV Tenecteplase Helps Before Stroke Thrombectomy: BRIDGE-TNK Todd Neale May 22, 2025
News Conference News AHA 2024 Rivaroxaban Doesn’t Cut Cognitive Decline, Stroke, or TIA in Younger AF Patients Shelley Wood November 16, 2024
News Conference News ESOC 2024 TEMPO-2: Tenecteplase No Help in Mild Stroke With Proven Occlusion Todd Neale May 23, 2024
News Conference News ACC 2024 Coronary Sinus Reducer Eases Symptoms in Refractory Angina: ORBITA-COSMIC Michael O'Riordan April 08, 2024
News Conference News ISC 2024 Tirofiban May Cut Early Worsening After Acute Ischemic Stroke Todd Neale February 13, 2024
News Conference News ISC 2024 MOST: Eptifibatide, Argatroban Don’t Improve on IV Thrombolysis Alone Todd Neale February 08, 2024
News Conference News ISC 2023 Tenecteplase Matches Up Well With Alteplase in Acute Stroke: TRACE-2 Todd Neale February 14, 2023
News Conference News AHA 2022 Pemafibrate Fails to Lower CVD Risk in Patients With High Triglycerides: PROMINENT Michael O'Riordan November 05, 2022
News Conference News EuroPCR 2022 MitraClip Helps for Atrial Functional MR: MITRA-TUNE Michael O'Riordan May 19, 2022
News Conference News ACC 2022 ADAPT-TAVR: Edoxaban No Better Than DAPT After TAVI Todd Neale April 05, 2022
News Conference News ACC 2022 APOLLO: Novel siRNA Injectable Cuts Lp(a) by Nearly 100% in Small Study Michael O'Riordan April 03, 2022
News Conference News ACC 2022 New HF Guidelines Stress Four-Drug Approach, ‘HFmrEF,’ Amyloidosis Options, and More Shelley Wood April 01, 2022
News Conference News AHA 2019 More Ischemia on Stress Echo Equals Greater Angina Benefit With PCI: ORBITA Michael O'Riordan November 14, 2019
News Conference News AHA 2018 EMPA-HEART Offers Mechanistic Clues for Empagliflozin’s Cardiac Benefits Michael O'Riordan November 16, 2018
News Conference News AHA 2018 Methotrexate, an Anti-inflammatory, Fails to Lower Risk of Cardiovascular Events: CIRT Michael O'Riordan November 10, 2018
News Conference News ACC 2017 ACC 2017: CVD Outcomes for Evolocumab, Intermediate-Risk TAVR, Coronary Physiology Tests, and More Shelley Wood March 10, 2017
News Conference News ACC 2014 Perioperative Aspirin Increases Major Bleeding After Noncardiac Surgery L.A. McKeown March 31, 2014